More on eculizumab for congenital atypical hemolytic-uremic syndrome.
Jae Il
JI
Shin
Jae Seung
JS
Lee
D000911:Antibodies, Monoclonal / Q000008:administration & dosage* / Q000493:pharmacokinetics; D061067:Antibodies, Monoclonal, Humanized; D003182:Complement C5 / Q000037:antagonists & inhibitors; D006463:Hemolytic-Uremic Syndrome / Q000151:congenital* / Q000188:drug therapy; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000493:pharmacokinetics; D007223:Infant; D008297:Male
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003182:Complement C5; D007155:Immunologic Factors; C481642:eculizumab